Yuhang Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuhang Zhou has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bei Huang
School of Life Sciences, Anhui University, Hefei 230601, China; Center for Stem Cell and Translational Medicine, Anhui University, Hefei 230601, China
2 shared publications - Kan He
Center for Stem Cell and Translational Medicine, School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, Anhui, China; Traditional Chinese Medicine Research Centre, School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, Anhui, China
2 shared publications - Alfred Sze Lok Cheng
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication Jian Zhang
School of Life Sciences, Anhui University, Hefei, 230601, China; Center for Stem Cell and Translational Medicine, Anhui University, Hefei, 230601, China
1 shared publication- Jun Yu
The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China
1 shared publication - Ka-Fai To
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication
Latest Publications
- 1 September 2020
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 200, 110736
Mechanism study of the beneficial effect of sodium selenite on metabolic disorders in imidacloprid-treated garlic plants
- 1 September 2020
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 200, 110736
Mechanism study of the beneficial effect of sodium selenite on metabolic disorders in imidacloprid-treated garlic plants
- 1 February 2020
- Published by Elsevier in Biochemical Pharmacology
- Vol. 172, 113752
1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway
- 1 February 2020
- Published by Elsevier in Biochemical Pharmacology
- Vol. 172, 113752
1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S27-S28
108 miR-377-3p/miR-1343-3p/miR-4269 Silence Activates TEAD1/4 to Promote Gastric Tumorigenesis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S27-S28
108 miR-377-3p/miR-1343-3p/miR-4269 Silence Activates TEAD1/4 to Promote Gastric Tumorigenesis